Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30


Human Red Blood Cells as Oxygen Carriers to Improve Ex-Situ Liver Perfusion in a Rat Model.

Dondossola D, Santini A, Lonati C, Zanella A, Merighi R, Vivona L, Battistin M, Galli A, Biancolilli O, Maggioni M, Villa S, Gatti S.

J Clin Med. 2019 Nov 8;8(11). pii: E1918. doi: 10.3390/jcm8111918.


Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines.

Cerchia C, Nasso R, Mori M, Villa S, Gelain A, Capasso A, Aliotta F, Simonetti M, Rullo R, Masullo M, De Vendittis E, Ruocco MR, Lavecchia A.

J Med Chem. 2019 Aug 8;62(15):7089-7110. doi: 10.1021/acs.jmedchem.9b00632. Epub 2019 Jul 24.


Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives.

Ehrsam D, Porta F, Mori M, Schwabedissen HEMZ, Dalla Via L, Garcia-Argaez AN, Basile L, Meneghetti F, Villa S, Gelain A.

Anticancer Res. 2019 Jul;39(7):3453-3461. doi: 10.21873/anticanres.13491.


New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents.

Chiarelli LR, Mori M, Beretta G, Gelain A, Pini E, Sammartino JC, Stelitano G, Barlocco D, Costantino L, Lapillo M, Poli G, Caligiuri I, Rizzolio F, Bellinzoni M, Tuccinardi T, Villa S, Meneghetti F.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):823-828. doi: 10.1080/14756366.2019.1589462.


An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis.

Mori M, Sammartino JC, Costantino L, Gelain A, Meneghetti F, Villa S, Chiarelli LR.

Curr Top Med Chem. 2019;19(9):646-661. doi: 10.2174/1568026619666190227182701. Review.


Exploring the Biological Activity of a Library of 1,2,5-Oxadiazole Derivatives Endowed With Antiproliferative Activity.

Gelain A, Mori M, Meneghetti F, Porta F, Basile L, Marverti G, Asai A, Hyeraci M, García-Argáez AN, Via LD, Guccione S, Villa S.

Anticancer Res. 2019 Jan;39(1):135-144. doi: 10.21873/anticanres.13089.


Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents.

Gelain A, Mori M, Meneghetti F, Villa S.

Curr Med Chem. 2019;26(27):5165-5206. doi: 10.2174/0929867325666180719122729. Review.


Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.

Chiarelli LR, Mori M, Barlocco D, Beretta G, Gelain A, Pini E, Porcino M, Mori G, Stelitano G, Costantino L, Lapillo M, Bonanni D, Poli G, Tuccinardi T, Villa S, Meneghetti F.

Eur J Med Chem. 2018 Jul 15;155:754-763. doi: 10.1016/j.ejmech.2018.06.033. Epub 2018 Jun 18.


New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies.

Pini E, Poli G, Tuccinardi T, Chiarelli LR, Mori M, Gelain A, Costantino L, Villa S, Meneghetti F, Barlocco D.

Molecules. 2018 Jun 21;23(7). pii: E1506. doi: 10.3390/molecules23071506.


Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors.

Villa S, Legnani L, Colombo D, Gelain A, Lammi C, Bongiorno D, Ilboudo DP, McGee KE, Bosch J, Grazioso G.

J Comput Aided Mol Des. 2018 Mar;32(3):473-486. doi: 10.1007/s10822-018-0102-5. Epub 2018 Jan 30.


Low density polyethylene functionalized with antibiofilm compounds inhibits Escherichia coli cell adhesion.

Dell'orto S, Cattò C, Villa F, Forlani F, Vassallo E, Morra M, Cappitelli F, Villa S, Gelain A.

J Biomed Mater Res A. 2017 Dec;105(12):3251-3261. doi: 10.1002/jbm.a.36183. Epub 2017 Sep 2.


A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity.

Porta F, Gelain A, Barlocco D, Ferri N, Marchianò S, Cappello V, Basile L, Guccione S, Meneghetti F, Villa S.

Chem Biol Drug Des. 2017 Nov;90(5):820-839. doi: 10.1111/cbdd.13003. Epub 2017 May 14.


An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.

Porta F, Facchetti G, Ferri N, Gelain A, Meneghetti F, Villa S, Barlocco D, Masciocchi D, Asai A, Miyoshi N, Marchianò S, Kwon BM, Jin Y, Gandin V, Marzano C, Rimoldi I.

Eur J Med Chem. 2017 May 5;131:196-206. doi: 10.1016/j.ejmech.2017.03.017. Epub 2017 Mar 15.


The response of Escherichia coli biofilm to salicylic acid.

Cattò C, Grazioso G, Dell'Orto S, Gelain A, Villa S, Marzano V, Vitali A, Villa F, Cappitelli F, Forlani F.

Biofouling. 2017 Mar;33(3):235-251. doi: 10.1080/08927014.2017.1286649. Epub 2017 Feb 20.


Iron Acquisition Pathways as Targets for Antitubercular Drugs.

Meneghetti F, Villa S, Gelain A, Barlocco D, Chiarelli LR, Pasca MR, Costantino L.

Curr Med Chem. 2016;23(35):4009-4026. Review.


Effects of Red Blood Cell Transfusions on the Risk of Developing Complications or Death: An Observational Study of a Cohort of Very Low Birth Weight Infants.

Ghirardello S, Dusi E, Cortinovis I, Villa S, Fumagalli M, Agosti M, Milani S, Mosca F.

Am J Perinatol. 2017 Jan;34(1):88-95. doi: 10.1055/s-0036-1584300. Epub 2016 Jun 1.


Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB): From Biological Insight to Inhibitors.

Fanzani L, Porta F, Meneghetti F, Villa S, Gelain A, Lucarelli AP, Parisini E.

Curr Med Chem. 2015;22(27):3110-32. Review.


Unravelling the Structural and Molecular Basis Responsible for the Anti-Biofilm Activity of Zosteric Acid.

Cattò C, Dell'Orto S, Villa F, Villa S, Gelain A, Vitali A, Marzano V, Baroni S, Forlani F, Cappitelli F.

PLoS One. 2015 Jul 1;10(7):e0131519. doi: 10.1371/journal.pone.0131519. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0136124.


Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Bennardello F, Coluzzi S, Curciarello G, Todros T, Villa S; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) and Italian Society of Gynaecology and Obstetrics (SIGO) working group.

Blood Transfus. 2015 Jan;13(1):109-34. doi: 10.2450/2014.0119-14. No abstract available.

Supplemental Content

Loading ...
Support Center